A novel polyclonal antibody library for expression profiling of poorly characterized, membrane and secreted human proteins

Journal of Proteomics

Volumn 75, Issue 2, 2011, Pages 532-547

  Grifantini, Renata ^a   Pagani, Massimiliano ^b,f   Pierleoni, Andrea ^a   Grandi, Alberto ^a   Parri, Matteo ^a   Campagnoli, Susanna ^a   Pileri, Piero ^a   Cattaneo, Davide ^b   Canidio, Elena ^b   Pontillo, Angela ^b   De Camilli, Elisa ^c   Bresciani, Alberto ^b   Marinoni, Federica ^b   Pedrazzoli, Eros ^b   Nogarotto, Renzo ^a   Abrignani, Sergio ^d   Viale, Giuseppe ^c   Sarmientos, Paolo ^a,b   Grandi, Guido ^e  

^a Externautics SpA   (Italy)

^b PRIMM   (Italy)

^c EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^d Externautics SpA and INGM   (Italy)

^e NOVARTIS VACCINES AND DIAGNOSTICS   (Italy)

^f INGM   (Italy)

Author keywords

Antibody collection; Human proteins; Immunohistochemistry; Tissue microarray

Indexed keywords

MEMBRANE PROTEIN; POLYCLONAL ANTIBODY; TUMOR PROTEIN;

ANIMAL EXPERIMENT; ANTIBODY LIBRARY; ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; FEMALE; GENETIC SELECTION; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; PROTEIN TARGETING; TISSUE MICROARRAY; WESTERN BLOTTING;

ANIMALS; ANTIBODIES; BREAST NEOPLASMS; ESCHERICHIA COLI; FEMALE; GENE EXPRESSION PROFILING; GENE LIBRARY; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MEMBRANE PROTEINS; MICE; PEPTIDE LIBRARY; PROSTATIC NEOPLASMS; PROTEIN ARRAY ANALYSIS; RECOMBINANT PROTEINS; TUMOR MARKERS, BIOLOGICAL;

MURINAE;

EID: 82355169497     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2011.08.018     Document Type: Article

References (24)

1. Sanders C.R., Myers J.K. Disease-related misassembly of membrane proteins. Annu Rev Biophys Biomol Struct 2004, 33:25-51.
2. Service R.F. Proteomics. Proteomics ponders prime time. Science 2008, 321:1758-1761.
3. Uhlen M., Bjorling E., Agaton C., Szigyarto C.A., Amini B., Andersen E., et al. A human protein atlas for normal and cancer tissues based on antibody proteomics. Mol Cell Proteomics 2005, 4:1920-1932.
4. Uhlen M., Ponten F. Antibody-based proteomics for human tissue profiling. Mol Cell Proteomics 2005, 4:384-393.
5. Nilsson P., Paavilainen L., Larsson K., Odling J., Sundberg M., Andersson A.C., et al. Towards a human proteome atlas: high-throughput generation of mono-specific antibodies for tissue profiling. Proteomics 2005, 5:4327-4337.
6. Martelli P.L., Fariselli P., Casadio R. An ENSEMBLE machine learning approach for the prediction of all-alpha membrane proteins. Bioinformatics 2003, 19:i205-i211.
7. Pierleoni A., Martelli P.L., Fariselli P., Casadio R. BaCelLo: a balanced subcellular localization predictor. Bioinformatics 2006, 22:e408-e416.
8. Pierleoni A., Martelli P.L., Casadio R. MemLoci: predicting subcellular localization of membrane proteins in Eukaryotes. Bioinformatics 2011, 27:1224-1230.
9. Altschul S.F., Gish W., Miller W., Myers E.W., Lipman D.J. Basic local alignment search tool. J Mol Biol 1990, 215:403-410.
10. Aslanidis C., de Jong P.J. Ligation-independent cloning of PCR products (LIC-PCR). Nucleic Acids Res 1990, 18:6069-6074.
11. Studier F.W. Protein production by auto-induction in high density shaking cultures. Protein Expr Purif 2005, 41:207-234.
12. Kononen J., Bubendorf L., Kallioniemi A., Barlund M., Schraml P., Leighton S., et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 1998, 4:844-847.
13. Kampf C., Andersson A.C., Wester K., Bjorling E., Uhlen M., Ponten F. Antibody-based Tissue profiling as tools for clinical proteomics. Clin Proteomics 2004, 285-299. 1 Ed.
14. Andreu P., Colnot S., Godard C., Laurent-Puig P., Lamarque D., Kahn A., et al. Identification of the IFITM family as a new molecular marker in human colorectal tumors. Cancer Res 2006, 1998(66):1949-1955.
15. Cheong S.C., Chandramouli G.V., Saleh A., Zain R.B., Lau S.H., Sivakumaren S., et al. Gene expression in human oral squamous cell carcinoma is influenced by risk factor exposure. Oral Oncol 2009, 45:712-719.
16. Fan J., Peng Z., Zhou C., Qiu G., Tang H., Sun Y., et al. Gene-expression profiling in Chinese patients with colon cancer by coupling experimental and bioinformatic genomewide gene-expression analyses: identification and validation of IFITM3 as a biomarker of early colon carcinogenesis. Cancer 2008, 113:266-275.
17. Kosari F., Asmann Y.W., Cheville J.C., Vasmatzis G. Cysteine-rich secretory protein-3: a potential biomarker for prostate cancer. Cancer Epidemiol Biomarkers Prev 2002, 11:1419-1426.
18. Bjartell A., Johansson R., Bjork T., Gadaleanu V., Lundwall A., Lilja H., et al. Immunohistochemical detection of cysteine-rich secretory protein 3 in tissue and in serum from men with cancer or benign enlargement of the prostate gland. Prostate 2006, 66:591-603.
19. Hammarstrom S. The carcinoembryonic antigen (CEA) family: structures, suggested functions and expression in normal and malignant tissues. Semin Cancer Biol 1999, 9:67-81.
20. Kuespert K., Pils S., Hauck C.R. CEACAMs: their role in physiology and pathophysiology. Curr Opin Cell Biol 2006, 18:565-571.
21. Leth-Larsen R., Lund R.R., Ditzel H.J. Plasma membrane proteomics and its application in clinical cancer biomarker discovery. Mol Cell Proteomics 2010, 9:1369-1382.
22. Wang Z.Q., Xing W.M., Fan H.H., Wang K.S., Zhang H.K., Wang Q.W., et al. The novel lipopolysaccharide-binding protein CRISPLD2 is a critical serum protein to regulate endotoxin function. J Immunol 2009, 183:6646-6656.
23. Wu F., Dassopoulos T., Cope L., Maitra A., Brant S.R., Harris M.L., et al. Genome-wide gene expression differences in Crohn's disease and ulcerative colitis from endoscopic pinch biopsies: insights into distinctive pathogenesis. Inflamm Bowel Dis 2007, 13:807-821.
24. Hisamatsu T., Watanabe M., Ogata H., Ezaki T., Hozawa S., Ishii H., et al. Interferon-inducible gene family 1-8U expression in colitis-associated colon cancer and severely inflamed mucosa in ulcerative colitis. Cancer Res 1999, 59:5927-5931.